Source: Nextleaf Solutions Ltd.
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Nextleaf (OILS) is commercializing its patented technology to produce THC-free Broad Spectrum CBD distillate from industrial hemp feedstock
  • The company recently produced THC-Free CBD and has validated its hemp extraction and manufacturing process through third-party analytical testing
  • The company can use new technology to further refine the CBD distillate below the defined threshold of less than 0.3% THC under the Cannabis Act’s definition of a pure CBD product
  • Nextleaf Solutions Ltd. (OILS) is up 7.14 per cent trading at $0.15 as of 9:45 am ET

Nextleaf (OILS) is commercializing its patented technology to produce THC-free Broad Spectrum CBD distillate from industrial hemp feedstock.

The company recently produced THC-Free CBD and has validated its hemp extraction and manufacturing process through third-party analytical testing.

The company can use new technology to further refine the CBD distillate below the defined threshold of less than 0.3 per cent THC under the Cannabis Act’s definition of a pure CBD product.

Nextleaf Co-Founder and CEO Paul Pedersen stated that this technology to remove the THC will get the tax out of CBD oils.

“Adding THC-Free CBD ingredients to our portfolio is further validation of our team’s ability to innovate and will help unlock mass market CBD therapeutic products.”

The company expects to announce more details in the coming weeks on the launch of its first THC-Free CBD product.

Nextleaf is a federally regulated manufacturer and distributor of cannabis vapes and oils under its prohibition-era brand, Glacial Gold.

Nextleaf Solutions Ltd. (OILS) is up 7.14 per cent trading at $0.15 as of 9:45 am ET.


More From The Market Herald

" Christina Lake Cannabis (CSE:CLC) recaps Q2 results

Christina Lake Cannabis (CLC) recap its second quarter financial results for the six-month period ended May 31, 2022.

" Aleafia Health (TSX:AH) earns record quarter-over-quarter revenue in Q1 2023

Aleafia Health (AH) reported its financial results for the three months ended June 30, 2022.
InnoCan - Founder and CEO, Iris Bincovich.

" Innocan Pharma (CSE:INNO) approaches 100 per cent CBD bioavailability for its LPT CBD liposomal delivery platform

Innocan Pharma (INNO) has announced results from a clinical study on dogs suffering from pain.

" Bhang (CSE:BHNG) President/CEO and Director stepping down

Bhang’s (BHNG) President/CEO and Director Jamie Pearson is stepping down after seven years with the company.